rating/target unchang post result mark solid enrol
strong sg control attract cf in-lin oper guidanc
mbr came estim partial impact risk
adjust expect improv medic cost trend see sever
area attract momentum across busi addit govern
growth remain strong dbg/clinic program fuel specialti
continu close profit gap risk/aso trim
pressur share mbr came ahead estim
consensu mbr guidanc /-
also consensu mbr came high end
rang impact risk adjust heavier flu impact
guidanc reflect pronounc impact mix given on-going
strength govern busi expect improv underli
medic cost trend also see sever area attract opportun
solid underli momentum core busi detail
execut mbr key could pocket near-
term chop primari remain upbeat underli trend
trim estim reflect elimin hif oper
expect unchang maintain rate price target
roll govern busi strong finish year
oper gain increas oper margin expand bp
medicaid side post-redetermin rate progress continu
expect on-going improv medicaid remain posit
medicaid growth prospect given compani expertis manag
complex patient popul sizabl pipelin opportun on-going rfp
success recent acquisit ne mo state busi
cnc/wcg transact addit member growth medicar also
remain robust follow strong compani expect grow
enrol member individu group
expect busi benefit strong core trend improv
pharmaci cost structur ingeniorx addit supplement benefit
nutrit consum engag platform continu view
attract posit grow group busi given commerci book
final continu think relationship blue provid
uniqu growth opportun across product view addit partnerships/
cross-sel opportun like time
tr target
tr target includ dividend
ingeniorx diversifi busi group capabl membership
transit ingeniorx see attract opportun grow membership
across product given meaning improv cost structur addit see sizabl
extern opportun time self-fund book penetr present signific
potenti growth forese futur on-going shift toward valu grow
value-bas spend year end upside/downsid arrang also expect
diversifi busi group provid addit growth tailwind given clinic program analytics/
ai capabl tele-health offer grow suit specialti solut remain bullish
pend beacon health acquisit expect close bolster
behavior health platform expect addit capabl enhanc strateg posit
particularli medicaid book compani also make headway toward goal reduc
technolog platform six two end plan consum
destin platform end expect platform simplif drive increas
effici addit cost leverag better patient experi potenti growth opportun
enrol member revenu oper gain larg due
launch ingeniorx greater penetr supplement servic compani expect
continu enrol growth fee-bas sector commerci risk enrol remain roughli flat
rel despit sizabl account move fulli insur aso specialti
growth similar within commerci improv sale effect remain area
focu taken sever step improv relationship resourc front end portal
sale manag technolog avail broker partner help make easier busi
with/driv product sale addit compani suit specialti product increasingli
reson specialti membership grow member outpac medic
membership growth expect anoth strong year final manag guid
impress local group medic cost trend /- bp tie meaning improv
pharmaci cost structur ingeniorx medic cost manag initi
guidanc revenu enrol in-lin expect
medic enrol oper total revenu vs
strhe benefit expens ratio came higher
estim strhe consensu impact risk adjust reduct
earlier anticip flu season cost good sold also higher better
expect sg vs strhe strong expens control improv leverag
lower tax kept bottom-lin track adjust ep in-lin consensu strhe
compani also provid full guidanc includ medic membership
vs strhe prior estim oper revenu approxim vs strhe
consensu adjust ep least would highlight oper
guidanc unchang adjust ep impact increment tie repeal
hif addit mbr expect rang /- bp vs strhe consensu
sg ratio expect /- bp local group medic cost trend
expect strong /- bp vs
strong estim updat flow remain strong cffo
come well ahead guidanc suggest anoth
strong cash flow year cffo expect addit day claim payabl decreas
day sequenti day compani exit debt-to-cap ratio
also rais quarterli dividend repurchas stock
leav avail current share repurchas author flexibl
remain attract given strong cash flow trend solid balanc sheet see signific
opportun continu augment core growth capit deploy trim full
year hif repeal lower base adjust ep estim
maintain hold rate price target unchang
page
oper revenu
oper revenu
product sold
total oper revenu
amort intang
page
revenu
revenu
lead provid healthcar benefit specialti product commerci
govern membership commerci compani largest busi segment member
compani boast signific local market share strong brand recognit also
sizabl medicaid presenc member strong trend medicar compani also
launch full suit pbm solut ingeniorx may expect fulli transit
ingeniorx begin
like antm scale local market share view bcb brand differenti see strong
growth opportun across sever compani busi line see price upsid
acceler launch ingeniorx sizabl exposur highli competit tougher growth
commerci market recent pressur medicaid segment bear watch
valuat risk
trade ep roughli in-lin manag care group averag
view appropri given compani strong underli fundament trend somewhat off-set
exposur slower growth commerci market recent medicaid headwind
price target base trade ep modest premium current multipl
view appropri given compani scale brand recognit local market share
expect futur benefit pharmaci upsid risk includ better expect growth
govern busi share gain commerci stronger pbm growth downsid risk includ
increas pressur commerci market advers regulatory/legisl chang pressur
medicaid busi difficulti grow govern pay busi challeng grow
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
